https://www.selleckchem.com/pr....oducts/Idarubicin.ht
5% (N = 2/128) of clinically relevant genotypes (supported in part by protein modeling) in CH-TD. No CNVs were identified, nor did polyAla 14 alanines in FOXE1 significantly protect against TD. The present and previously published data collectively show that small clinically relevant germline variants in PAX8, FOXE1, and TSHR are found in only a very small proportion (2.5%) of isolated CH-TD Mexican patients.ATM is among of the most critical initiators and coordinators of the DNA-damage response. ATM canonical and non-canonical